The effects of β-blockers in patients with stable chronic heart failure.: Predictors of left ventricular ejection fraction improvement and impact on prognosis

被引:29
作者
de Groote, Pascal
Delour, Pierre
Mouquet, Frederic
Lamblin, Nicolas
Dagorn, Joeel
Hennebert, Olivier
Le Tourneau, Thierry
Foucher-Hossein, Claude
Verkindere, Christine
Bauters, Christophe
机构
[1] Ctr Hosp Reg & Univ Lille, Hop Cardiol, Serv Cardiol C, F-59037 Lille, France
[2] Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Nucl Med Serv, F-59037 Lille, France
关键词
D O I
10.1016/j.ahj.2007.05.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies, with limited number of patients, have tried to determine the predictors of left ventricular ejection fraction (LVEF) improvement after beta-blockade. No study has demonstrated that LVEF improvement was an independent predictor of cardiac survival. Methods The aims of the study were to determine in a large group of patients with stable chronic heart failure associated with reduced LVEF the predictors of LVEF improvement (difference in LVEF [delta LVEF], ie, the value after p-blockade minus the value before beta-blockade) after beta-blockade and to analyze prognostic impact of delta LVEF. Three hundred fourteen consecutive patients underwent an echocardiogram, a radionuclide angiogram, and a maximum cardiopulmonary exercise test before and 3 months after maximal tolerated doses of beta-blockers have been reached. Results After beta-blockade, LVEF improved from 30% +/- 11 % to 40% 13%. In the whole population, independent predictors of delta LVEF were nonischemic etiology, baseline LVEF (negative correlation), and baseline heart rate (positive correlation. In ischemic patients, independent predictors of delta LVEF were absence of history of myocardial infarction, baseline heart rate, and baseline LVEF; whereas in nonischemic patients, independent predictors were baseline LVEF and baseline QRS width (negative correlation). After 1082 days of follow-up, there were 53 cardiovascular deaths and 2 urgent transplantations. Left ventricular ejection fraction improvement (defined as an absolute increase in LVEF >5%) was an independent predictor of cardiac survival. Patients who had an LVEF :! <= 45% after beta-blockade with a delta LVEF :<= 55% represented a high-risk subgroup. Conclusions in patients with chronic heart failure, predictors of LVEF improvement after beta-blockade were different according to etiology. Left ventricular ejection fraction improvement was an independent predictor of cardiac survival.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 24 条
[1]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[2]   Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy [J].
Bello, D ;
Shah, DJ ;
Farah, GM ;
Di Luzio, S ;
Parker, M ;
Johnson, MR ;
Cotts, WG ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Gheorghiade, M ;
Kim, RJ .
CIRCULATION, 2003, 108 (16) :1945-1953
[3]   DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY [J].
BRISTOW, MR ;
OCONNELL, JB ;
GILBERT, EM ;
FRENCH, WJ ;
LEATHERMAN, G ;
KANTROWITZ, NE ;
ORIE, J ;
SMUCKER, ML ;
MARSHALL, G ;
KELLY, P ;
DEITCHMAN, D ;
ANDERSON, JL .
CIRCULATION, 1994, 89 (04) :1632-1642
[4]   Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial [J].
Cleland, JGF ;
Pennell, DJ ;
Ray, SG ;
Coats, AJ ;
Macfarlane, PW ;
Murray, GD ;
Mule, JD ;
Vered, Z ;
Lahiri, A .
LANCET, 2003, 362 (9377) :14-21
[5]   Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure [J].
de Groote, P ;
Millaire, A ;
Foucher-Hossein, C ;
Nugue, O ;
Marchandise, X ;
Ducloux, G ;
Lablanche, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) :948-954
[6]   Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with β-blockade in patients with heart failure -: The β-Blocker Evaluation of Survival Trial (BEST) [J].
Eichhorn, EJ ;
Grayburn, PA ;
Mayer, SA ;
Sutton, MS ;
Appleton, C ;
Plehn, J ;
Oh, J ;
Greenberg, B ;
DeMaria, A ;
Frantz, R ;
Krause-Steinrauf, H .
CIRCULATION, 2003, 108 (19) :2336-2341
[7]   Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure [J].
Groenning, BA ;
Nilsson, JC ;
Sondergaard, L ;
Fritz-Hansen, T ;
Larsson, HBW ;
Hildebrandt, PR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2072-2080
[8]   TIME-COURSE OF IMPROVEMENT IN LEFT-VENTRICULAR FUNCTION, MASS AND GEOMETRY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE TREATED WITH BETA-ADRENERGIC-BLOCKADE [J].
HALL, SA ;
CIGARROA, CG ;
MARCOUX, L ;
RISSER, RC ;
GRAYBURN, PA ;
EICHHORN, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) :1154-1161
[9]  
Hjalmarson Å, 1999, LANCET, V353, P2001
[10]  
Hunt SA, 2005, CIRCULATION, V112, pE154, DOI [10.1161/CIRCULATIONAHA.105.167586, 10.1161/CIRCULATIONAHA.105.167587]